Congo (the)

in page functions
[French]
Congo
Total population (2018) 4,995,574
Birth cohort (2018) 172,773
Surviving Infants (surviving to 1 year per year, 2018) 165,377
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 33/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 45/1000
World Bank Index, IDA (2015) 3.00
Gross Nation Income (per capita US$, 2015) 2,540
No. of districts/territories (2017) 41

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Congo

Type of support

Approvals

2001-2023 (US$)
(29 Mar 2019)

Commitments

2001-2023 (US$)
(29 Mar 2019)

Disbursements

2000-2018 (US$)
(29 Mar 2019)

% Disbursed

(29 Mar 2019)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $29,183,607 $29,218,746 $29,251,340
Graduation grant (GG) $375,372 $410,511 $375,372 100%
Health system strengthening (HSS 1) $5,199,999 $5,199,999 $5,199,999 100%
Immunisation services support (ISS) $1,665,000 $1,665,000 $1,665,000 100%
Injection Safety Devices (NVS) $86,000 $86,000 $87,054 101%
Injection safety support (INS) $224,534 $224,534 $224,534 100%
IPV (NVS) $1,405,369 $1,405,369 $910,869 65%
MR-Catch-up campaign (NVS) $746,000 $746,000 $796,857 107%
Penta (NVS) $7,846,759 $7,846,759 $8,102,721 103%
Pneumo (NVS) $7,042,651 $7,042,651 $7,427,691 105%
Rotavirus (NVS) $1,627,250 $1,627,250 $1,662,146 102%
Tetra DTP-HepB (NVS) $827,822 $827,822 $827,822 100%
Vaccine Introduction Grant (VIG) $810,000 $810,000 $633,000 78%
Yellow Fever (NVS) $1,326,851 $1,326,851 $1,338,275 101%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Congo DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 80%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2010) 72.30%
Household survey: DTP3 coverage for female (2010) 71.40%
Household survey: Last DTP3 survey (2010) 72%
% districts achieving > 80% DTP3 coverage (2017) 24%
% districts achieving < 50% DTP3 coverage (2017) 24%
MCV WHO/UNICEF estimates (2017) 70%

Breakdown of support

Non-vaccine support Vaccine support
28% 72%
$8,097,905 $21,153,435

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Congo

03 April 2019

mozambique

Cholera vaccination campaign begins in Mozambique

Following Cyclone Idai devastation, nearly 900,000 people will receive the vaccine from the Gavi-funded stockpile.

27 March 2019

Gavi item

Leadership training for supply chain managers expands to five African countries

Over 22 private sector partners will support the innovative training and mentorship programme.

14 March 2019

The Vaccine Goal

Pneumococcal vaccine price drops for third year running

In agreement with Gavi, Pfizer reduces price of pneumococcal vaccine to US$ 2.90 per dose for Gavi-eligible countries.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here